CD8A and neoplasm: Furthermore, the aPD‐L1 as an immune checkpoint after interacting with PD‐L1 is expressed on the tumor cells, ultimately enhancing the CD8+ T‐cell effector activity.[132] The above nanoplatform exhibited precise targeting effects by virtue of the combination of two strategies and realized high tumor cell uptake simultaneously.